Pasithea Therapeutics Corp. Warrant (KTTAW) Financials

KTTAW Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 30.7 million 2.3 million
2023-06-30 38.1 million 2.6 million
2023-03-31 42.0 million 2.9 million
2022-12-31 45.2 million 2.7 million

KTTAW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.6 million 126674
2023-06-30 -3.5 million 218634
2023-03-31 -3.3 million 177021
2022-12-31 -6.2 million 156174

KTTAW Net Income

No data available :(

KTTAW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 19.6 million - 385288
2023-06-30 26.6 million - 425760
2023-03-31 29.9 million - 465454
2022-12-31 33.1 million - 926887

KTTAW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 25.2 million
2023-06-30 26.1 million
2023-03-31 26.1 million
2022-12-31 25.3 million

KTTAW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 22659 1.6 million 2.2 million -
2023-06-30 3108 2.0 million 1.8 million -
2023-03-31 53888 1.1 million 2.1 million -
2022-12-31 1.8 million 1.4 million 3.9 million -

KTTAW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 162256
2023-06-30 - 163217
2023-03-31 - 162680
2022-12-31 240712 1308

KTTAW

Price: $0.01

52 week price:
0.01
0.02

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3000

Market Capitalization: 11.2 million

Links: